Related Experiment Video
Updated: May 24, 2026

Evaluation of Changes in Hydration and Body Cell Mass with Bioelectrical Impedance Analysis after Exercise Program for Rheumatoid Arthritis Patients
Published on: July 14, 2023
Body fat percent and fat distribution parameters in rheumatic diseases
M Z Okçu1, S Yardımcı, S Çomoğlu
1Ankara Physical Therapy and Rehabilitation Hospital, Ankara, Turkey.
Abstract:
Alterations in body composition in chronic rhematologic disorders have been associated with decreased strength, altered energy metabolism and immunologic compromise and may provide a useful indicator of the severity of the disease. However, results of anthropometric parameter studies have been equivocal. The purpose of this study, was to compare body composition parameters of patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with those of healthy controls. Mean age, height, weight and body mass index (BMI) of patients with RA were not found to be different from those of the controls. BMI, body fat percent (BFP) were found to be high in patients with AS, but the differences between this two parameters of AS patients and controls were not statistically significant. Mean BFP of patients with RA was higher than the control subjects, but only the difference between female patients with RA and controls was statistically significant. Mean lean body mass (LBM) was slightly lower in male and female patients with RA compaired to the healthy controls. LBM of AS patients was found to be similar with that of the controls. Upper/lower body fat ratio (U/L BFR) and central/peripheral body fat ratio (C/P BFR) were higher in male patients with RA, but there were no differences between patients and controls. U/L BFR and C/P BFR body fat ratios were higher in AS patients. But, only the differences between C/P body fat distribution of AS patients and control subjects was statistically significant. The results obtained from this preliminary report show some anthropometric parameters of RA and AS patients can differ from those of the healthy controls. Future investigations are needed to determine the metabolic alterations causing the changes in body composition.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
